Morgan Stanley Upgrades Hill-Rom Holdings to Overweight with Price Target $62.00

Brokerage firm Morgan Stanley Upgrades its rating on Hill-Rom Holdings(NYSE:HRC). In a research note issued to the investors, the brokerage major Raises the price-target to $62.00 per share. The shares have been rated Overweight. Previously, the analysts had a Equal-weight rating on the shares. The rating by Morgan Stanley was issued on Jun 16, 2016.

Hill-Rom Holdings (HRC) made into the market gainers list on Tuesdays trading session with the shares advancing 0.10% or 0.05 points. Due to strong positive momentum, the stock ended at $51.12, which is also near the day’s high of $51.29. The stock began the session at $51.05 and the volume stood at 5,93,517 shares. The 52-week high of the shares is $58.73 and the 52 week low is $42.99. The company has a current market capitalization of $3,342 M and it has 6,53,82,880 shares in outstanding.

Hill-Rom Holdings(HRC) last announced its earnings results on Apr 29, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $632.60M. Analysts had an estimated revenue of $651.80M. Earnings per share were $0.71. Analysts had estimated an EPS of $0.70.

Several Insider Transactions has been reported to the SEC. On May 17, 2016, Jason Richardson (VP, Controller & CAO) sold 2,952 shares at $47.80 per share price.Also, On Mar 16, 2015, Richard G Keller (VP, Controller & CAO) sold 4,996 shares at $48.42 per share price.On Feb 12, 2015, Alton Shader (Sr VP & Pres Post Acute Care) sold 15,253 shares at $46.30 per share price, according to the Form-4 filing with the securities and exchange commission.

Hill-Rom Holdings Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility Wound Care and Prevention Clinical Workflow Surgical Safety and Efficiency and Respiratory Health. The Company operates in three segments: North America Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services as well as its clinical workflow solutions in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *